Who We Are:
Magellan Life Sciences is a synthetic biology company that discovers and develops plant inspired proteins for commercial applications in Food and Beverage industries. Magellan’s proprietary protein production platform XSeed® bridges the gap from R&D to consumer markets by allowing for economically viable industrial scale production of unique natural proteins.
**Our Product: **
The sweet tasting protein Brazzein is the leading product from our pipeline. **Brazzein holds significant commercial potential as the next-gen protein sweetener that is 1200 times sweeter than sugar, zero caloric, pH and heat stable. ****Unlike all its competitors, Brazzein has a sugar-like taste with no bitter or metallic aftertaste, thus requiring zero masking agents, thereby reducing formulation and product costs; a high value proposition for today’s F&B industry. **Using XSeed®, we have developed a patented commercially viable production process for Brazzein. Magellan is currently seeking strategic investment for its seed round, joint ventures and collaborations for scaling our production and commercialization of Brazzein.
**Our Technology: **
XSeed® Platform- Our proprietary synthetic biology-based platform is built upon a vast library of proprietary synthetic secretion signal molecules. Engineering of product-specific, production strains with the appropriate combinations of these secretion signals allows for extremely high titers of secreted product. Proprietary, effective and simplified Down-Stream Processing protocols complement XSeed® enabling Magellan to reach unrivaled lower production costs.
Magellan Life Sciences NewsVIEW ALL
You might also be interested in
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.